Key Findings on Brain Metastases in Breast Cancer
How common are brain metastases in metastatic breast cancer, and what differences exist among the various breast cancer subtypes? A study involving 2,775 patients examines these questions.
Brain metastases remain a major challenge in metastatic breast cancer. A recent analysis of 2,775 patients shows that brain metastases developed in approximately 17 percent of them over the course of the disease. HER2-positive and triple-negative tumors were particularly affected. The results underscore the importance of early risk assessment and targeted therapies tailored to the specific type of breast cancer.
The study is based on so-called real-world data from an Austrian breast cancer registry. Unlike in a traditional clinical trial, no specific treatment is prescribed: the study analyzes data from actual medical care and the real-world disease progression of patients.
Prof. Dr. med. Michael Knauer of the Tumor- und Brustzentrum Ostschweiz is a co-author of the publication and was involved in designing the study.
Published online in *The Breast*
